213 related articles for article (PubMed ID: 9110171)
1. Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains.
Oeltjen JC; Malley TM; Muzny DM; Miller W; Gibbs RA; Belmont JW
Genome Res; 1997 Apr; 7(4):315-29. PubMed ID: 9110171
[TBL] [Abstract][Full Text] [Related]
2. Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci.
Oeltjen JC; Liu X; Lu J; Allen RC; Muzny D; Belmont JW; Gibbs RA
Mamm Genome; 1995 May; 6(5):334-8. PubMed ID: 7626884
[TBL] [Abstract][Full Text] [Related]
3. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
[TBL] [Abstract][Full Text] [Related]
5. Physical mapping in the region of the Bruton's tyrosine kinase and alpha-galactosidase A gene loci in proximal Xq22.
Sweatman AK; Bradley LA; Lovering RC; O'Reilly MA; Levinsky RJ; Kinnon C
Hum Genet; 1994 Dec; 94(6):624-8. PubMed ID: 7989038
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.
Himmelmann A; Thevenin C; Harrison K; Kehrl JH
Blood; 1996 Feb; 87(3):1036-44. PubMed ID: 8562928
[TBL] [Abstract][Full Text] [Related]
7. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells.
Pan J; Xia L; McEver RP
J Biol Chem; 1998 Apr; 273(16):10058-67. PubMed ID: 9545353
[TBL] [Abstract][Full Text] [Related]
8. Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I.
Egloff AM; Desiderio S
J Biol Chem; 2001 Jul; 276(30):27806-15. PubMed ID: 11373296
[TBL] [Abstract][Full Text] [Related]
9. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
11. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
12. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
13. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.
Yang W; Desiderio S
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):604-9. PubMed ID: 9012831
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
15. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
[TBL] [Abstract][Full Text] [Related]
16. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulatory elements within the first intron of Bruton's tyrosine kinase.
Rohrer J; Conley ME
Blood; 1998 Jan; 91(1):214-21. PubMed ID: 9414287
[TBL] [Abstract][Full Text] [Related]
20. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.
Cheng G; Ye ZS; Baltimore D
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8152-5. PubMed ID: 8058772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
